SPERO BIOPHARMA

Committed to the prevention and treatment of Alzheimer's disease

Scientist in the Lab
 
Pipetting Samples

BACKGROUND

Spero Biopharma Ltd. was founded by Prof. Marta Weinstock-Rosin, a world renowned researcher of Alzheimer disease. Prof. Weinstock-Rosin is the inventor of Exelon®, a blockbuster drug for the treatment of Alzheimer’s disease, and a professor emeritus at the Hebrew University’s School of Pharmacy-Institute for Drug Research in the Faculty of Medicine.

 
Closeup of a Petri Dish

WHAT WE DO

Spero Biopharma’s lead compound is Ladostigil, an innovative treatment for Mild Cognitive Impairment (MCI)

  • Mechanism of action involves multiple neuro-protection functions Including reduction of microglial  activation and inhibition of pro-inflammatory cytokines

  • A rich body of preclinical data

  • Ladostigil has completed a multinational phase-II trial in mild cognitive impairment with positive final results 

  • World class scientific founder and advisory board

  • Comprehensive IP coverage

 
Microscope

"Big results require big ambitions"

Heraclitus

 

GET IN TOUCH

Thanks for submitting!